Is This the End of Cancer Research as We Know It?

1. Announcement of a 15% cap on facilities and administrative costs by NIH 2. Concerns about the impact on cancer research infrastructure and potential lay-offs 3. Threat to the leading position of the U.S. in biomedical research and innovation 4. Highlighting the necessity of sustained investments in the NIH and NCI 5. Appropriation of language protecting the NIH's funding levels, programmatic guidance, and F&A rates in a continuing resolution bill